ReproCELL (United Kingdom)
REPROCELL Biopta’s human tissue technology enables more accurate prediction of clinical success by using the most physiologically relevant models of human drug response.By bridging the gap between animal studies and clinical trials, human tissue testing provides a powerful translational approach that improves clinical success rates and enhances the commercial value of preclinical assets through proof of concept in patient-derived living tissues. REPROCELL enables cell therapy developers with int
Basic Information
- Category: business
- Website: https://www.reprocell.com/#
Documented Facts
- Phone: +1-301-470-3362 (No linked source recorded for this statement.)
- Email: info-us@reprocell.com (No linked source recorded for this statement.)
Evidence and Sources
- ReproCELL (United Kingdom) — Official Site (official)
- ReproCELL (United Kingdom) on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about ReproCELL (United Kingdom).
- Canonical profile: https://brandsource.ai/brands/reprocell-united-kingdom
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/reprocell-united-kingdom/json-ld
- Citation profile API: https://brandsource.ai/api/brands/reprocell-united-kingdom/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (84/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
REPROCELL Biopta’s human tissue technology enables more accurate prediction of clinical success by using the most physiologically relevant models of human drug response.By bridging the gap between animal studies and clinical trials, human tissue testing provides a powerful translational approach that improves clinical success rates and enhances the commercial value of preclinical assets through proof of concept in patient-derived living tissues. REPROCELL enables cell therapy developers with int
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.